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Objectives This study analyzed whether lower calf muscle density and poorer upper and lower extremity strength are associ-
ated with higher mortality rates in men and women with peripheral arterial disease (PAD).
Background Men and women with lower extremity PAD have lower calf muscle density and reduced lower extremity strength
compared with individuals without PAD.
Methods At baseline, participants underwent measurement of calf muscle density with computed tomography in addition
to knee extension power and isometric knee extension, plantar flexion, and hand grip strength measures. Partici-
pants were followed up annually for up to 4 years. Results were adjusted for age, sex, race, body mass index,
ankle-brachial index, smoking, physical activity, and comorbidities.
Results Among 434 PAD participants, 103 (24%) died during a mean follow-up of 47.6 months. Lower calf muscle den-
sity was associated with higher all-cause mortality (lowest density tertile hazard ratio [HR]: 1.80 [95% confi-
dence interval (CI): 1.07 to 3.03], second tertile HR: 0.91 (95% CI: 0.51 to 1.62); highest density tertile HR:
1.00; p trend  0.020) and higher cardiovascular disease mortality (lowest density tertile HR: 2.39 [95% CI:
0.90 to 6.30], second tertile HR: 0.85 [95% CI: 0.27 to 2.71]; highest density tertile HR: 1.00; p trend  0.047).
Poorer plantar flexion strength (p trend  0.004), lower baseline leg power (p trend  0.046), and poorer hand-
grip (p trend  0.005) were associated with higher all-cause mortality.
Conclusions These data demonstrate that lower calf muscle density and weaker plantar flexion strength, knee extension
power, and hand grip were associated with increased mortality in these participants with PAD, independently of
the ankle-brachial index and other confounders. (J Am Coll Cardiol 2012;59:1159–67) © 2012 by the
American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.12.019Lower extremity peripheral arterial disease (PAD) affects 8
million men and women in the United States (1). The
prevalence is expected to increase as the population lives
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2011, accepted December 14, 2011.longer with chronic disease. Men and women with PAD
have greater lower extremity functional impairment and
faster functional decline than people without PAD (2,3).
Lower extremity skeletal muscle, particularly calf muscle, is
the end organ affected by obstructed lower extremity arteries
in PAD. Consistent with this association, individuals with
PAD have more adverse calf muscle characteristics and
poorer lower extremity strength than people without PAD
(4,5). Histopathologic data demonstrate that lower extrem-
ity ischemia is associated with calf muscle apoptosis, type II
muscle fiber atrophy, and impaired mitochondrial function
(5–7). An improved understanding of the prognostic signif-
icance of lower extremity muscle pathophysiological
changes in PAD may help delineate mechanisms of adverse
outcomes in PAD.
We studied associations of computed tomography (CT)-
measured calf muscle density, calf muscle area, and calf
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rates in men and women with
PAD. We hypothesized that
lower calf muscle density, lower
calf muscle area, and higher calf
muscle percent fat would be as-
sociated with higher all-cause
and cardiovascular disease mor-
tality. We also studied associa-
tions of knee extension power,
knee extension isometric strength,
and plantar flexion isometric strength with mortality in
people with PAD. We hypothesized that poorer knee exten-
ion power, knee extension strength, and plantar flexion
trength would be associated with higher all-cause and
ardiovascular disease mortality. To determine whether
ssociations of poorer strength with higher mortality are
ystemic in people with PAD, we studied associations of
and grip isometric strength with mortality.
ethods
tudy overview. The institutional review boards of North-
estern University and Catholic Health Partners Hospital
pproved the protocol. Participants provided written in-
ormed consent. Participants were part of the WALCS II
Walking and Leg Circulation Study II), a prospective,
bservational study designed to identify associations of calf
keletal muscle characteristics and leg strength with func-
ional performance and functional decline in people with
nd without PAD (4,8,9). Participants underwent baseline
easures and returned annually for follow-up. Participants
ere also followed up for the outcome of mortality.
articipant identification. PAD participants in WALCS
I included 223 patients with PAD attending their fourth
nnual follow-up visit in the original WALCS (4,8) and
40 with PAD newly identified for WALCS II.
PAD participants were identified from among consecu-
ive patients diagnosed with PAD in 3 Chicago-area non-
nvasive vascular laboratories (4,8,9). A small number of
AD participants were identified from among consecutive
atients in a large general internal medicine practice who
ere found to have a low ankle-brachial index (ABI) at their
tudy visit and were included among PAD participants
4,8). PAD was defined as an ABI 0.90 at the baseline
isit for WALCS II (4,8). All participants were age 59
ears at baseline.
Participation rates and exclusion criteria for the WALCS
I cohort have been described previously (4,9). The follow-
ng exclusion criteria were applied at the time of original
tudy enrollment to participants in the original WALCS
ohort and those newly identified. Patients with dementia
ere excluded because of their inability to answer questions
ccurately. Nursing home residents, wheelchair-bound pa-
ients, and patients with foot or leg amputations were
Abbreviations
and Acronyms
ABI  ankle-brachial index
BMI  body mass index
CT  computed
tomography
HR  hazard ratio
PAD  peripheral arterial
diseasexcluded because they had severely impaired functioning.on–English-speaking patients were excluded because the
nvestigators were not fluent in non-English languages.
atients with recent major surgery were also excluded.
BI measurement. A handheld Doppler probe (Nicolet
ascular Pocket- Dop II; Nicolet Biomedical Inc., Golden,
olorado) was used to obtain systolic pressures in the right
nd left brachial, dorsalis pedis, and posterior tibial arteries
2,4,8). Each pressure was measured twice. The ABI was
alculated by dividing the mean of the dorsalis pedis and
osterior tibial pressures in each leg by the mean of the 4
rachial pressures (2,4,8). Zero values for the dorsalis pedis
nd posterior tibial pulses were set to missing for the ABI
alculation. Average brachial pressures in the arm with
ighest pressure were used when one brachial pressure was
igher than the opposite brachial pressure in both measure-
ent sets and the 2 brachial pressures differed by 10 mm
g in at least 1 measurement set; this action was taken
ecause in such cases, subclavian stenosis was possible (10).
he lowest leg ABI was used in analyses.
easuring calf skeletal muscle characteristics. We stud-
ed calf muscle characteristics because the superficial femoral
rtery is the most common site of lower extremity athero-
clerosis (11,12) and calf musculature receives blood supply
rom the superficial femoral artery. Furthermore, the calf
uscles are those that classically are symptomatic in patients
ith PAD (13). Using a CT scanner (LightSpeed, GE
edical Systems, Waukesha, Wisconsin), 2.5-mm cross-
ectional images of the calves were obtained at 66.7% of the
istance from the distal to the proximal tibia without
ontrast (4,9). Cross-sectional calf muscle images were
nalyzed by using BonAlyse (BonAlyse Oy, Jyväskylä,
inland), a software for processing CT images that identi-
es muscle tissue, fat, and bone (4,9). The muscle outline
as traced manually, excluding subcutaneous fat and bone,
y a study coordinator who was trained and certified in these
easures before beginning analyses. When quantifying
uscle area, the BonAlyse software quantifies voxels within
range corresponding to muscle density (9 to 271 mg/cm3)
and excludes voxels corresponding to fat density (–270 to 8
mg/cm3). Intramuscular fat is quantified by summing voxels
corresponding to fat tissue density within muscle tissue.
Previous cadaver studies demonstrated that these methods
provide an estimate of muscle cross-sectional area and fat
content that are highly correlated with direct anatomic
measures (14). Specifically, correlations between CT-
measured skeletal muscle and lipid content with corre-
sponding measures from cadavers were 0.97 and 0.96,
respectively. Because larger individuals require greater mus-
cle mass to support their larger frame, muscle area was
adjusted for the square of individual tibia length (4,9).
Muscle density is a measure of muscle quantity within a
defined volume. Across the voxel range corresponding to
muscle tissue (9 to 271 mg/cm3), individuals have varying
quantities of muscle per centimeter cubed (i.e., they range
from 9 to 271). Mean muscle density was calculated per
p
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March 27, 2012:1159–67 Muscle Density and Mortality in Peripheral Arterial Diseaseindividual, representing the quantity of muscle measured
per centimeter cubed (9).
Isometric strength measures. Knee extension isometric
strength was measured in Newtons using a computer-linked
strength chair (Good Strength Chair, Metitur Oy, Jyväs-
kylä, Finland) (15). Transducers were placed for measure-
ment of knee extension, plantar flexion, and hand grip
strength. Data were collected electronically by computer
over 6 s. Strength measurements using the Good Strength
Chair have high test–retest reliability (Pearson product
moment correlations  0.88 to 0.96) (15). Two trials were
erformed, and the maximum strength was used in analyses
8,15).
eg power. Validated methods developed by Bassey et al.
ere used to measure knee extension power in Watts (8,16).
he power rig uses a flywheel that is accelerated by pushing
footplate until the leg is extended (16). Power is derived
rom the final velocity of the flywheel measured with an
ptiswitch attached to a microcomputer. Testing was stopped
hen at least 5 trials had been performed and the 2 highest
easures were within 5% of each other. Up to 9 trials were
erformed (8,16).
ortality assessment. The Social Security Administration
eath database was used to search for deaths through
ovember 12, 2010. At baseline, each participant provided
ames of 3 proxies to assist with ascertaining complete
ollow-up. Mortality information was also obtained from
amily members, proxies, and primary care physicians.
eath certificates were obtained from the State of Illinois or
rom the patients’ medical record. Cardiovascular disease
eaths were those with International Classification of
iseases-10th Revision, codes in the range of I01.0 through
99.9, including deaths due to coronary heart disease,
troke, peripheral vascular disease, and other cardiovascular
isease.
omorbidities. Comorbidities assessed included diabetes,
ngina, myocardial infarction, heart failure, cancer, chronic
ung disease, and stroke. Disease-specific algorithms that
ombine data from patient report, medical record review,
edications, laboratory values, and a questionnaire com-
leted by the participant’s primary care physician were used
o verify and document baseline comorbidities other than
nee and hip arthritis on the basis of criteria previously
eveloped (17).
ther measures. Height and weight were measured at
he study visit. Body mass index (BMI) was calculated as
eight (kilograms)/(height [meters squared]). Cigarette
moking history was determined with patient report.
hysical activity was assessed using validated methods to
scertain patient report of the number of blocks walked
uring the past week (18).
tatistical analyses. Baseline characteristics between men
nd women were compared using general linear models for
ontinuous variables and chi-square tests for categorical
ariables. Among men and women with PAD, respectively,
haracteristics of decedents and survivors were compared Psing general linear models for continuous variables and
hi-square tests for categorical variables.
We used proportional hazards analyses to compare all-
ause and cardiovascular disease mortality rates across ter-
iles of each calf muscle characteristic (calf muscle area, calf
uscle percent fat, and calf muscle density), adjusting for
ge, sex, and race. These analyses were designated model 1.
ertiles of calf muscle characteristics were selected, rather
han quartiles, because the number of deaths, particularly
ardiovascular deaths, was relatively low. Next, these pro-
ortional hazards analyses were repeated with additional
djustment for comorbidities (diabetes, angina, myocardial
nfarction, heart failure, cancer, lung disease, and stroke),
moking (pack-years), BMI, physical activity, and ABI.
hese analyses were designated model 2. Similar methods
ere used to evaluate associations of knee extension power,
sometric knee extension strength, plantar flexion strength,
nd hand grip strength with all-cause and cardiovascular
isease mortality. PROC PHREG in SAS was used to
erform these analyses. P trend values were calculated to
etermine whether associations across tertiles of muscle
easures represented linear trends.
In our WALCS cohort, we previously identified sex
ifferences in associations of isometric knee extension
trength with functional decline and mortality among par-
icipants with PAD (19,20). Therefore, we first assessed
ssociations of each calf muscle characteristic and strength
easure with mortality separately among men and women.
hen the association of a specific muscle measure with
ortality was similar between men and women, data from
en and women were combined. Associations of muscle
easures with mortality were considered similar for men
nd women when the following criteria were met: 1) there
as no interaction of sex on the association of the muscle
easure with mortality; and 2) the direction of the associ-
tion between the third versus the first tertile for each
uscle measure with mortality was the same for men and
omen, adjusting for age, sex, and race. Based on these
riteria, data for men and women were not combined for
ssociations of calf muscle percent fat with all-cause mor-
ality or for associations of isometric leg strength, hand grip,
nd plantar flexion strength with cardiovascular mortality.
Analyses were performed using SAS statistical software
ersion 9.1 (SAS Institute Inc., Cary, North Carolina).
esults
total of 434 participants with PAD underwent CT
maging of calf skeletal muscle at baseline and are included
n these analyses. Of these, 391 had knee extension power
easured, 319 had isometric knee extension measured, 330
ad isometric plantar flexion measured, and 329 had iso-
etric hand grip measured at baseline. Mean follow-up was
7.6  15.8 months.
Table 1 shows characteristics of the men and women withAD. Women with PAD included a higher proportion of
e for th
BMI 
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Muscle Density and Mortality in Peripheral Arterial Disease March 27, 2012:1159–67African Americans and lower proportions of participants
with diabetes, angina, and heart failure compared with men
with PAD.
Table 2 shows characteristics of survivors and dece-
dents among men and women with PAD, respectively.
Overall, there were 62 (26.6%) deaths among men and 41
(20.3%) deaths among women. Among the 52 male
decedents with death certificates, 22 (42%) deaths were
Characteristics of Men and Women With PADTable 1 Characteristics of Men and Women
Overall (N  434)
Age, yrs 75 8.2
African American 16.6
BMI, kg/m2 27.9 5.1
ABI 0.63 0.2
Current smoker 15.2
Diabetes 32.3
Cancer 20.3
Hypertension 73.5
Angina 35.8
Myocardial infarction 26.3
Stroke 21.0
Heart failure 29.3
Pulmonary disease 44.2
ACE inhibitors 29.5
Statin therapy 55.3
Beta-blocker therapy 42.6
Values are mean  SD or %. The p value shown represents the p valu
ABI  ankle-brachial index; ACE  angiotensin-converting enzyme;
Characteristics of Survivors and Decedents Among Men and WomeTable 2 Characteristics of Survivors and Decedents Among Me
Men
Survival
(n  171)
Decedents
(n  62)
Age, yrs 73.6 7.8 76.3 8.5
BMI 28.4 4.6 28.1 4.8
ABI 0.65 0.15 0.61 0.16
African American 8.8 13.0
Current smoker 13.5 19.4
Diabetes 34.5 43.6
Cancer 17.5 21.0
Hypertension 72.5 67.7
Stroke 21.6 24.2
Heart failure 29.8 43.6
Pulmonary disease 35.1 61.3
Angina 39.4 50.0
Myocardial infarction 27.1 32.3
Calf muscle area, mm2 6,307 1,330 5,673 1,32
Muscle percent fat 10.0 11.7 13.0 11.5
Calf muscle density, g/cm3 33.5 4.2 31.5 4.0
Knee extension power, W 123.9 52.1 94.49 51.0
Isometric knee extension strength,
Newtons
335.2 113.2 290.9 90.3
Isometric hand grip, Newtons 354.0 99.2 300.14 99.8
Isometric plantar flexion, Newtons 391.3 182.3 274.0 136Values are mean  SD or %.
Abbreviations as in Table 1.due to cardiovascular disease and 12 (23%) were due to
cancer. Among the 34 female decedents with death
certificates, 13 (38%) deaths were due to cardiovascular
disease and 9 (26%) were due to cancer. In both men and
women, decedents were older than survivors (Table 2).
Among men, decedents included a higher proportion of
participants with pulmonary disease compared with sur-
vivors. Among men and women, respectively, decedents
PAD
le (n  201) Male (n  233) p Value
.9 8.2 74.4 8.1 0.056
24.4 9.9 0.0001
.4 5.6 28.3 4.6 0.057
62 0.16 0.64 0.15 0.368
15.4 15.0 0.908
26.9 36.9 0.026
22.4 18.5 0.310
76.1 71.2 0.251
28.1 42.2 0.002
23.9 28.5 0.282
19.4 22.3 0.457
24.4 33.5 0.038
46.8 42.1 0.325
26.4 32.2 0.185
52.7 57.5 0.319
42.3 42.9 0.895
e comparison of values between men and women.
body mass index; PAD  peripheral arterial disease.
th PADd Women With PAD
p Value
Women
p Value
Survival
(n  160)
Decedents
(n  41)
0.027 75.1 8.2 78.7 7.5 0.014
0.706 27.8 5.6 25.8 5.6 0.04
0.138 0.62 0.15 0.64 0.19 0.479
0.350 26.3 17.1 0.222
0.265 13.1 24.4 0.075
0.206 26.3 29.3 0.697
0.552 23.1 19.5 0.621
0.477 76.3 75.6 0.932
0.679 18.1 24.4 0.365
0.050 21.9 34.2 0.103
0.001 46.3 48.8 0.772
0.149 26.3 35.0 0.274
0.437 22.5 29.3 0.365
0.002 4,692 1,054 4,261 1,012 0.020
0.096 11.9 14.0 13.0 15.3 0.665
0.002 32.3 3.9 31.1 4.1 0.0812
0.001 67.65 33.7 53.84 30.7 0.0351
0.015 212.1 72.9 182.4 61.3 0.0653
0.001 190.86 62.2 160.70 59.8 0.031
0.001 296.0 159.8 255.8 117.9 0.245With
Fema
75
27
0.n Win an
7
.4
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March 27, 2012:1159–67 Muscle Density and Mortality in Peripheral Arterial Diseasehad lower calf muscle area, lower knee extension power,
and lower handgrip compared with survivors. Among
men, decedents had lower calf muscle density and lower
knee extension isometric strength compared with survi-
vors (Table 2).
Within the entire cohort, lower calf muscle density was
associated with higher all-cause mortality, adjusting for age,
sex, and race in model 1 (Fig. 1) (p  0.016). This
association was not substantially changed after additional
adjustment for comorbidities, smoking, BMI, physical ac-
tivity, and ABI in model 2 (p 0.020). Similarly, lower calf
muscle density was associated with higher cardiovascular
disease mortality, adjusting for age, sex, and race in model 1
Figure 1
Adjusted Association of Baseline
Calf Muscle Density With All-Cause Mortality
in Participants With PAD (N  420)
Model 1: adjusted for age, sex, and race. Model 2: adjusted for covariates in
model 1 and the ankle-brachial index, body mass index, comorbidities, physical
activity, smoking history, and study cohort (WALCS [Walking and Leg Circulation
Study] vs. WALCS II). 1: p  0.008 for the comparison between the highest
and lowest tertiles. 2: p  0.028 for the comparison between the highest and
lowest tertiles. PAD  peripheral arterial disease.
Figure 2 Adjusted Associations of Baseline Calf Muscle Densit
Cardiovascular Disease Mortality in Participants With
Model 1: Adjusted for age, sex, and race. Model 2: adjusted for covariates in mod
smoking history, and study cohort (WALCS vs. WALCS II). 1: p  0.020, as compa(Fig. 2) (p  0.012). This association remained statistically
significant after additional statistical adjustment for comor-
bidities, smoking, BMI, physical activity, and ABI in model 2
(p  0.047). Within the entire cohort, we identified no
significant associations of calf muscle area with all-cause
mortality or cardiovascular disease mortality in either model
1 or 2 (Table 3).
Within the entire cohort, lower knee extension power was
associated with higher all-cause mortality, adjusting for age,
sex, and race in model 1 (Fig. 3) (p trend  0.004). This
association was maintained after additional statistical ad-
justment for comorbidities, BMI, ABI, physical activity,
and smoking in model 2 (p trend  0.046). Lower plantar
flexion strength was associated with higher all-cause mor-
tality, adjusting for age, sex, and race in model 1 (Fig. 4) (p
trend 0.001). This association remained statistically sig-
nificant even after additional adjustment for BMI, ABI,
physical activity, comorbidities, and smoking in model 2 (p
trend  0.004). Lower hand grip strength was associated
with higher all-cause mortality, adjusting for age, sex, and
race in model 1 (p trend  0.006). This association
remained statistically significant even after additional ad-
justment for BMI, ABI, physical activity, and smoking in
model 2 (Table 3) (p trend  0.005). Poorer knee extension
strength was associated with higher all-cause mortality,
adjusting for age, sex, and race in model 1 (p trend 
0.038). However, this association was not statistically sig-
nificant after additional adjustment for comorbidities, ABI,
BMI, physical activity, and smoking in model 2 (p trend 
0.185).
Associations of calf muscle percent fat with all-cause
mortality and associations of isometric knee extension
strength, hand grip, and plantar flexion strength with
cardiovascular mortality differed between men and women,
h
(N  420)
nd the ankle-brachial index, body mass index, comorbidities, physical activity,
the reference group of Tertile 3 in Model 1. Abbreviations as in Figure 1.y Wit
PAD
el 1 a
red to
re at ba
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Muscle Density and Mortality in Peripheral Arterial Disease March 27, 2012:1159–67according to our criteria. Therefore, these associations are
reported separately for men and women. Among men and
women with PAD, respectively, there were no significant
associations of calf muscle percent fat with all-cause mor-
tality, adjusting for age, sex, race, ABI, BMI, smoking, and
Associations of Lower Extremity Muscle Measures With All-CauseTable 3 Associations of Lower Extremity Muscle Measures Wit
Measure
Tertile 1
(Poorest Muscle Measure at Base
Calf muscle area and all-cause mortality
Model 1 1.62 (0.92–2.85)
Model 2 1.43 (0.77–2.32)
Hand grip and all-cause mortality
Model 1 1.81 (0.94–3.48)
Model 2 1.71 (0.89–3.32)
Knee extension isometric strength
and all-cause mortality
Model 1 2.44 (1.18–5.02)
Model 2 1.96 (0.90–4.26)
Calf muscle area and
cardiovascular mortality
Model 1 2.84 (0.89–9.05)
Model 2 2.56 (0.74–8.84)
Calf muscle percent fat and
cardiovascular mortality
Model 1 0.63 (0.25–1.58)
Model 2 0.81 (0.30–2.51)
Knee extension power and
cardiovascular mortality
Model 1 8.78 (1.94–39.81)
Model 2 8.89 (1.86–42.43)
Values are hazard ratios (95% confidence intervals). Model 1 adjusts for age, sex, and race; mode
1 and smoking, BMI, ABI, physical activity, comorbidities, and study cohort (WALCS vs. WALCS II). Th
(tertile 1) and tertile 2 are compared. Thus, the hazard ratio group for the reference is 1.0 and haza
1 refers to the best muscle measure at baseline, and Tertile 3 refers to the worst muscle measur
Abbreviations as in Table 1.
Figure 3 Adjusted Associations of Baseline Knee Extension Po
Model 1: adjusted for age, sex, and race. Model 2: adjusted for covariates in mod
smoking history, and study cohort (WALCS vs. WALCS II). 1: p  0.006: as compa
reference group of Tertile 3 in Model 2. Abbreviations as in Figure 1.comorbidities (p trend  0.427 for men and p  0.282 for
women).
Because of the relatively few cardiovascular deaths
among women with baseline strength measures (n  7),
esults were unstable. Therefore, data are presented only
ality in Men and Women With PAD*-Cause ortality in Men and Women With PAD*
Tertile 2
Tertile 3
(Best Muscle Measure at Baseline)
Trend
p Value
1.35 (0.77–2.37) 1.00 (reference) 0.050
1.30 (0.73–2.32) 1.00 (reference) 0.137
0.95 (0.48–1.87) 1.00 (reference) 0.006
0.86 (0.42–1.74) 1.00 (reference) 0.005
3.00 (1.46–6.16) 1.00 (reference) 0.038
2.70 (1.27–5.70) 1.00 (reference) 0.185
2.50 (0.79–7.89) 1.00 (reference) 0.305
2.63 (0.81–8.59) 1.00 (reference) 0.584
0.91 (0.42–1.95) 1.00 (reference) 0.188
1.12 (0.50–2.51) 1.00 (reference) 0.298
2.85 (0.58–13.92) 1.00 (reference) 0.002
3.24 (0.65–16.15) 1.00 (reference) 0.006
he calf muscle area measure also adjusts for tibia length. Model 2 adjusts for variables in model
ertile at baseline (tertile 3) serves as the reference group against which the worst tertile at baseline
for tertiles 1 and 2 are relative to this reference. *For the Calf muscle percent fat measure, Tertile
seline.
ith All-Cause Mortality in Participants With PAD (N  391)
nd the ankle-brachial index, body mass index, comorbidities, physical activity,
the reference group of Tertile 3 in Model 1. 2: p  0.038, as compared to theMorth All
line)
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March 27, 2012:1159–67 Muscle Density and Mortality in Peripheral Arterial Diseasefor men. Because of the small number of cardiovascular
deaths among men with baseline isometric strength
measures (n  18), results are presented according to
whether the baseline isometric strength measures were
above or below the median value. Among men, poorer
plantar flexion strength (p trend  0.006) and poorer
and grip (p trend  0.002) were associated with higher
ardiovascular disease mortality, adjusting for age, sex,
ace, BMI, physical activity, smoking, comorbidities,
BI, and study cohort (Table 4) (model 2). We did not
dentify significant associations of knee extension isomet-
ic strength with cardiovascular disease mortality among
en.
Figure 4 Adjusted Associations of Baseline Plantar Flexion Str
Model 1: adjusted for age, sex, and race. Model 2: adjusted for covariates in mod
smoking history, and study cohort (WALCS vs. WALCS II). 1: p  0.0003, as comp
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he results presented here show that lower calf muscle
ensity was associated with higher all-cause and cardiovas-
ular disease mortality among these participants with PAD.
ower knee extension power, poorer plantar flexion
trength, and poorer hand grip strength were associated
ith higher all-cause mortality in participants with PAD.
oorer plantar flexion strength and poorer hand grip
trength were associated with higher cardiovascular disease
ortality in men with PAD. These associations remained
tatistically significant even after adjustment for age, sex,
omorbidities, physical activity, ABI, and other covariates.
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Muscle Density and Mortality in Peripheral Arterial Disease March 27, 2012:1159–67To our knowledge, no previous studies have described
associations of CT-measured calf muscle characteristics,
knee extension power, hand grip isometric strength, or
plantar flexion isometric strength with all-cause or cardio-
vascular mortality in individuals with PAD.
Adverse lower extremity muscle characteristics may be
associated with higher mortality in people with PAD if
muscle characteristics reflect the extent of lower extremity
atherosclerosis and/or the overall health of an individual.
Previous studies (4,5,8) have demonstrated that adverse calf
muscle characteristics and poorer lower extremity strength
are associated with poorer functional performance among
individuals with PAD. Poorer functional performance is
associated with higher all-cause and cardiovascular mortality
rates in PAD (21). This previously established association of
poorer functional performance with higher rates of all-cause
and cardiovascular disease mortality in PAD (21) may
reflect the association of impaired lower extremity strength
with higher mortality rates reported here.
Our study design does not allow us to discern why some,
but not all, measures of calf muscle characteristics and
strength were associated significantly and independently
with mortality. However, some muscle measures may better
represent atherosclerotic disease burden and overall health
than other measures. For example, compared with isometric
measures of lower extremity strength, knee extension power
is a more sophisticated measure of muscle function that
incorporates measures of strength, peripheral nervous sys-
tem function, and central nervous system function. Our
finding that poorer grip strength was associated with higher
all-cause mortality may reflect the fact that grip strength is
a measure of overall health and frailty.
Hazard ratios for associations of muscle measures were
typically greater for cardiovascular disease than for all-cause
mortality. Our finding that muscle measures were associated
with all-cause mortality reflects, in part, the strong associ-
ation of muscle measures with cardiovascular disease mor-
tality and may also reflect that most PAD participants who
died of cancer were likely to have had simultaneous cardio-
vascular disease that may also have contributed to death.
A previous study from the InCHIANTI (Aging in the
Chianti Area) cohort reported no significant associations of
calf muscle density, calf muscle area, or calf muscle percent
fat with mortality among individuals without PAD (22).
The InCHIANTI study included 934 community-dwelling
individuals age 65 years without PAD living in 2 com-
unities in Italy who were followed up for a mean of 5.1
ears. Although lower calf muscle density, lower calf muscle
rea, and higher calf muscle percent fat were each associated
ith higher mortality in unadjusted analyses, none of these
ssociations remained statistically significant after additional
djustment for age and sex. A separate study from Health
BC, which included 2292 men and women without
AD who were age 70 to 79 years, reported that weaker
uadriceps isometric strength and weaker hand grip
sometric strength were associated with higher mortality, adjusting for covariates including age, sex, race, and
omorbidities (23). However, investigators found no
ignificant associations of thigh muscle area with mortal-
ty. Together, these previous studies and results reported
ere suggest that associations of lower extremity muscle
easures with mortality may differ between individuals
ith PAD versus without PAD.
We previously reported that poorer isometric knee exten-
ion strength was associated with higher all-cause mortality
n 264 men with PAD in the original WALCS cohort,
ndependently of age, sex, race, comorbidities, ABI, and
ther confounders (19). However, this previous study
howed no significant association of weaker isometric knee
xtension strength with higher cardiovascular disease mor-
ality among men and no significant associations of weaker
sometric knee extension strength with all-cause or cardio-
ascular disease mortality in 146 women with PAD. The
urrent study identified no significant associations of knee
xtension isometric strength with mortality in men or
omen with PAD. Compared with our original WALCS
tudy, the WALCS II study used a different method for
easuring knee extension strength and included a shorter
ollow-up period. These differences may account for the
lightly different results in the current study compared with
he previous study.
In contrast to the report by Singh et al. (19), the
urrent study includes data on associations of CT-
easured calf muscle density, calf muscle percent fat, and
alf muscle area in addition to isometric hand grip,
lantar flexion strength, and knee extension power with
ortality among participants with PAD. Thus, the cur-
ent report includes substantially new data compared with
reviously reported measures of muscle and mortality
mong participants with PAD.
tudy limitations. First, data are observational, and causal
ssociations cannot be construed. Second, the number of
ardiovascular deaths was low, particularly among women.
he small number of cardiovascular deaths limited the
tatistical power to test the associations of muscle measures
ith cardiovascular outcomes and resulted in relatively wide
onfidence intervals of the point estimates for cardiovascular
eaths. Third, we did not have data on PAD location, and
ocation of lower extremity atherosclerosis may have influ-
nced some of the associations studied here. Fourth, our
esults may have been influenced by residual confounding of
ge on the association of muscle characteristics with mor-
ality. Fifth, although previous histopathologic data dem-
nstrated that PAD is associated with calf muscle apoptosis,
ype II muscle fiber atrophy, and impaired mitochondrial
unction (5–7), the WALCS II cohort did not include these
easures, and therefore we could not relate these histo-
athologic findings to mortality. Sixth, although previous
tudies have found that reduced leg strength and power are
ssociated with gait abnormalities in individuals with PAD
nd claudication (24), the current study did not include data
1167JACC Vol. 59, No. 13, 2012 McDermott et al.
March 27, 2012:1159–67 Muscle Density and Mortality in Peripheral Arterial Diseaseon gait abnormalities. Seventh, not all study participants
had data for all strength measures.
Conclusions
Poorer calf muscle density, plantar flexion strength, knee
extension power, and hand grip were associated with
higher mortality in these individuals with PAD. Further
study is needed to determine whether interventions, such
as exercise, can reverse the adverse pathophysiological
lower extremity muscle findings in individuals with PAD
and whether these interventions improve survival in men
and women with PAD.
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